Page last updated: 2024-09-02

fingolimod and bay 11-7082

fingolimod has been researched along with bay 11-7082 in 1 studies

Compound Research Comparison

Studies
(fingolimod)
Trials
(fingolimod)
Recent Studies (post-2010)
(fingolimod)
Studies
(bay 11-7082)
Trials
(bay 11-7082)
Recent Studies (post-2010) (bay 11-7082)
650515701383

Protein Interaction Comparison

ProteinTaxonomyfingolimod (IC50)bay 11-7082 (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.82
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)2
Nuclear factor NF-kappa-B p100 subunit Homo sapiens (human)2
Transcription factor p65Homo sapiens (human)2.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Anderson, E; Ekins, S; Foil, DH; Havener, TM; Hickey, AJ; Makarov, V; Monakhova, N; Puhl, AC; Rank, L; Riabova, O; Zorn, KM1

Other Studies

1 other study(ies) available for fingolimod and bay 11-7082

ArticleYear
Multiple approaches to repurposing drugs for neuroblastoma.
    Bioorganic & medicinal chemistry, 2022, 11-01, Volume: 73

    Topics: Bayes Theorem; Cell Line, Tumor; Child; Child, Preschool; Crizotinib; Drug Repositioning; Etoposide; Fingolimod Hydrochloride; Humans; Neuroblastoma; Niclosamide

2022